Sheila Banks

Sheila has decades of experience in the pharmaceutical industry, CRO, and academic research settings. Her background encompasses operational oversight and accountability for Phase I–IV clinical trial deliverables from study startup to closeout. She has a broad range of therapeutic expertise including oncology, central nervous system, women’s health, internal medicine, dermatology, cardiovascular, and ophthalmology.

At Parexel, Sheila is responsible for the successful delivery of global and regional clinical timelines through positive leadership of multi-functional matrix study teams.